We are live on ! Find out more
OSH

Oak Street Health, Inc.
OSH

Delisted

OSH was delisted on the 1st of May, 2023.

Back to rankings

3 hedge funds and large institutions have $8.5M invested in Oak Street Health, Inc. in 2023 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 269 closing their positions.

New
Increased
Maintained
Reduced
Closed

99% less funds holding

Funds holding: 272 → 3 (-269)

100% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 269

100% less capital invested

Capital invested by funds: $8.38B → $8.5M (-$8.37B)

100% less funds holding in top 10

Funds holding in top 10: 26 → 0 (-26)

Holders
3
Holders Change
-269
Holders Change %
-98.9%
% of All Funds
0.05%
Holding in Top 10
–
Holding in Top 10 Change
-26
Holding in Top 10 Change %
-100%
% of All Funds
–
New
1
Increased
–
Reduced
–
Closed
269
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
GA
General Atlantic
New York
-$2.37B
2
NP
Newlight Partners
New York
-$1.26B
3
Vanguard Group
Vanguard Group
Pennsylvania
-$471M
4
Capital World Investors
Capital World Investors
California
-$362M
5
HI
HBK Investments
Texas
-$193M
Name Holding Trade Value Shares
Change 		Change in
Stake
Citadel Advisors
26
Citadel Advisors
Florida
– -$61.4M -1,587,371 Closed
DKCM
27
Davidson Kempner Capital Management
New York
– -$61.1M -1,579,379 Closed
SSA
28
Schonfeld Strategic Advisors
New York
– -$56.6M -1,462,075 Closed
JP Morgan Chase
29
JP Morgan Chase
New York
– -$55.8M -1,443,648 Closed
GF
30
Gabelli Funds
New York
– -$51.3M -1,326,971 Closed
GCL
31
Glazer Capital LLC
New York
– -$50.5M -1,305,865 Closed
FTCM
32
First Trust Capital Management
Illinois
– -$48.9M -1,265,000 Closed
KC
33
Kryger Capital
United Kingdom
– -$47M -1,215,270 Closed
Barclays
34
Barclays
United Kingdom
– -$43.5M -1,124,336 Closed
AllianceBernstein
35
AllianceBernstein
Tennessee
– -$42M -1,086,169 Closed
NAM
36
Nexpoint Asset Management
Texas
– -$41.1M -1,063,741 Closed
RG
37
Redmile Group
California
– -$41.1M -1,061,295 Closed
Schroder Investment Management Group
38
Schroder Investment Management Group
United Kingdom
– -$39.6M -1,024,582 Closed
AA
39
AQR Arbitrage
Connecticut
– -$38.9M -1,004,598 Closed
Norges Bank
40
Norges Bank
Norway
– -$37.3M -964,038 Closed
Bank of America
41
Bank of America
North Carolina
– -$35.1M -907,833 Closed
Millennium Management
42
Millennium Management
New York
– -$32.7M -845,034 Closed
NYLIM
43
New York Life Investment Management
New York
– -$29.9M -773,899 Closed
Goldman Sachs
44
Goldman Sachs
New York
– -$27.7M -717,003 Closed
SGCM
45
Sand Grove Capital Management
United Kingdom
– -$26.6M -688,813 Closed
Charles Schwab
46
Charles Schwab
California
– -$26.6M -688,406 Closed
GCIA
47
Gabelli & Co Investment Advisers
New York
– -$25.9M -669,200 Closed
Bank of Nova Scotia
48
Bank of Nova Scotia
Ontario, Canada
– -$25.8M -667,191 Closed
WIC
49
Water Island Capital
New York
– -$23.7M -613,951 Closed
Northern Trust
50
Northern Trust
Illinois
– -$23.7M -612,300 Closed
1
2
3 4 5

OSH Hedge Fund Activity: Q2 2023 in Review

3 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in Oak Street Health, Inc. (OSH) for Q2 2023, worth a combined $8.5M — down 100% from $8.38B a quarter earlier.

Sellers outnumbered buyers: 269 funds closed out of OSH and 1 opened new positions — a net loss of 268 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was General Atlantic, exiting entirely with an estimated $2.37B sold.

  • 3 institutional investors held Oak Street Health, Inc. (OSH) as of Q2 2023, down from 272 in Q1 2023.
  • Funds reported $8.5M of Oak Street Health, Inc. stock for Q2 2023, down 100% quarter-over-quarter.
  • 1 fund opened new Oak Street Health, Inc. positions in Q2 2023 and 269 closed out, a net change of -268 holders.
  • The largest Oak Street Health, Inc. seller in Q2 2023 was General Atlantic, an estimated $2.37B sold.

Based on aggregated 13F filings for Q2 2023.